Risk of acute leukemia and myelodysplastic syndromes in patients with monoclonal gammopathy of undetermined significance (MGUS): a population-based study of 17 315 patients
about
Simultaneous Manifestation of Chronic Myelomonocytic Leukemia and Multiple Myeloma during Treatment by Prednisolone and Eltrombopag for Immune-Mediated Thrombocytopenic Purpura.The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network.Variable risk of second primary malignancy in multiple myeloma patients of different ethnic subgroups.Diagnosis and management of smoldering multiple myeloma: the razor's edge between clonality and cancer.New cancers after autotransplantations for multiple myeloma.Characterization of monoclonal gammopathy of undetermined significance by calorimetric analysis of blood serum proteome.Two Secondary Primary Malignancies after Bortezomib Therapy for Multiple Myeloma: A Single-center Experience.Update on second primary malignancies in multiple myeloma: a focused review.Secondary malignancies in patients with multiple myeloma, Waldenström macroglobulinemia and monoclonal gammopathy of undetermined significance.Concomitant MDS with isolated 5q deletion and MGUS: case report and review of molecular aspects.Second primary malignancies in multiple myeloma: an overview and IMWG consensus.Myelopoiesis dysregulation associated to sustained APRIL production in multiple myeloma-infiltrated bone marrow.Guidelines for screening and management of late and long-term consequences of myeloma and its treatment.The presence of monoclonal gammopathy in Ph-negative myeloproliferative neoplasms is associated with a detrimental effect on outcomes.Therapy-related myelodysplastic syndrome/acute leukemia after multiple myeloma in the era of novel agentsImmunophenotypic alterations of bone marrow myeloid cell compartments in multiple myeloma patients predict for myelodysplasia-associated cytogenetic alterations
P2860
Q33435162-C51E97EC-AA6F-4E42-ADA9-6E51207FD859Q33695919-DB5EBE32-2C16-481A-9B2B-01B360EB1D88Q34283333-F76DF568-56AE-4C3B-84CF-93C998DBB7B8Q34557651-D678A1F7-609D-4FDF-B6F0-E46BA3088014Q35177465-7AAE3449-C457-49AE-9FAF-CCF4C060A949Q35202780-F026154E-AF98-43EF-82DC-DDBAA04F0205Q37615593-869F98AC-CA51-4E57-8BF8-5FC34F41F1D7Q38178031-496B05EF-A68B-4DF2-968F-C66859FC097DQ38933428-B60FEC9B-78DA-4061-B617-8CDAFABE4635Q39013004-B1B80C58-AD71-4578-9E96-1468EFB7AFABQ39013620-A10D9588-03AF-47EC-A7B6-D9E5A0F1062CQ41261844-B547B222-1162-4158-A2F5-820CA2B805A9Q47587127-9F5DB639-7BEA-428D-BC4D-11A8BC753E29Q48176112-AD29B540-FF22-49A4-9601-64563BFDA46CQ57904303-446BF2E1-A231-44AE-A8E0-5D35287E2A5CQ58010072-D09ADA34-FD24-4097-A367-4F4B092F4673
P2860
Risk of acute leukemia and myelodysplastic syndromes in patients with monoclonal gammopathy of undetermined significance (MGUS): a population-based study of 17 315 patients
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Risk of acute leukemia and mye ...... based study of 17 315 patients
@en
type
label
Risk of acute leukemia and mye ...... based study of 17 315 patients
@en
prefLabel
Risk of acute leukemia and mye ...... based study of 17 315 patients
@en
P2093
P2860
P50
P356
P1433
P1476
Risk of acute leukemia and mye ...... based study of 17 315 patients
@en
P2093
P2860
P2888
P304
P356
10.1038/LEU.2013.34
P577
2013-02-05T00:00:00Z